Orthobiologic is the broad term for using biologic products in orthopaedic surgery—ranging from stem cell injections to matched donor bone and cartilage transplantation. This is an exciting and promising new field in orthopaedic surgery and Dr. Richard Goding offers all of the newest, highest technology treatments, as well as the time-tested gold standards.
Each patient and each joint has its own story, and what may be the best treatment for one patient may not be the most appropriate for another patient. Dr. Richard Goding is one of the few orthopaedic surgeons in the nation who offers the full spectrum of treatments in this field. He offers each patient a personalized plan that goes beyond the initial treatment —Dr. Richard Goding remains involved in your care until your joint problem is solved.
Joint Preservation Institute of Iowa offers:
- Stem Cell Therapy
- Bone Marrow Concentrate Injections
- IRAP Injections
- Matrix Induced Autologous Chondrocyte Implants (MACI)
- Osteochondral Autograft Transfer System (OATS)
- Chondrofix® Matched Allograft (Cartilage Transplant)
- Superior Capsular Reconstruction
- Resurfacing Shoulder Replacement
The Joint Preservation Institute of Iowa is now offering stem cell therapy in Des Moines.
Dr. Richard Goding is one of the first orthopaedic surgeons in the nation to offer this treatment. He uses autologous stem cell therapy and the regenerative power of mesenchymal stem cells to give patients another treatment option for dealing with orthopaedic conditions, such as osteoarthritis and other degenerative joint conditions. Read More >
MACI is a new procedure that treats the articular cartilage defects of the knee by assisting regeneration of cartilage and restoring flexibility. Articular cartilage is a tissue that covers the surface of the joints and is responsible for pain-free movement of the bones within the joint. If the articular cartilage is damaged, the ends of the bones rub against each other, causing pain. MACI is indicated for patients with significant cartilage defects causing joint pain, swelling and catching in the knee. Read More >
Osteoarticular transfer system (OATS) is a surgical procedure used to treat isolated cartilage defects, which are usually 10 to 20 milimeters in size. The procedure transfers cartilage plugs taken from non-weight bearing areas of the joint and to the damaged areas of the joint. Read More >
DeNovo® grafts are tissue grafts used in cartilage repair. These grafts consist of cartilage tissue collected from donors or grown in the laboratory using human donated cartilage cells. There are two forms — DeNovo® ET (engineered tissue) and DeNovo® NT (natural tissue). Read More >
Chondrofix® Osteochondral Allograft takes the repair of full-thickness osteochondral lesions to a new level of convenience. Chondrofix is the first off-the-shelf osteochondral allograft, and each graft combines the inherent qualities of donated human bone and cartilage with the advantages of simplicity and safety. It is intended for homologous use to repair osteochondral lesions in diarthrodial joints. Read More >
Subchondroplasty is a minimally invasive, fluoroscopically assisted procedure that targets and fills subchondral bone defects through the delivery of AccuFill® BSM, a highly porous, nanocrystalline injectable calcium phosphate. Read More >
Superior capsular reconstruction is a new procedure for treating large “unfixable” rotator cuff tears. This procedure, which is done on an outpatient basis almost fully arthroscopically, uses a graft to reconstruct the shoulder capsule when the rotator cuff tendon tears are too large to repair. By reconstructing the capsule, a cushion is placed between the ball of the shoulder joint and the acromion bone. Additionally, the joint is held in anatomic position, allowing for restoration of normal shoulder function. Read More >
Total shoulder replacement is a very successful procedure performed for shoulder arthritis. However, there are some significant limitations. The shoulder replacement does not tolerate heavy use and will wear out over time, making it a poor choice for younger patients. Read More >